1. Home
  2. TFPM vs ALKS Comparison

TFPM vs ALKS Comparison

Compare TFPM & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TFPM
  • ALKS
  • Stock Information
  • Founded
  • TFPM 2016
  • ALKS 1987
  • Country
  • TFPM Canada
  • ALKS Ireland
  • Employees
  • TFPM N/A
  • ALKS N/A
  • Industry
  • TFPM Precious Metals
  • ALKS Biotechnology: Pharmaceutical Preparations
  • Sector
  • TFPM Industrials
  • ALKS Health Care
  • Exchange
  • TFPM Nasdaq
  • ALKS Nasdaq
  • Market Cap
  • TFPM 5.7B
  • ALKS 4.9B
  • IPO Year
  • TFPM N/A
  • ALKS 1991
  • Fundamental
  • Price
  • TFPM $28.13
  • ALKS $27.39
  • Analyst Decision
  • TFPM Strong Buy
  • ALKS Strong Buy
  • Analyst Count
  • TFPM 3
  • ALKS 14
  • Target Price
  • TFPM $23.67
  • ALKS $41.29
  • AVG Volume (30 Days)
  • TFPM 617.1K
  • ALKS 2.0M
  • Earning Date
  • TFPM 11-04-2025
  • ALKS 10-23-2025
  • Dividend Yield
  • TFPM 0.79%
  • ALKS N/A
  • EPS Growth
  • TFPM N/A
  • ALKS 21.99
  • EPS
  • TFPM 0.86
  • ALKS 2.08
  • Revenue
  • TFPM $324,214,000.00
  • ALKS $1,505,296,000.00
  • Revenue This Year
  • TFPM $33.78
  • ALKS N/A
  • Revenue Next Year
  • TFPM $3.53
  • ALKS $1.66
  • P/E Ratio
  • TFPM $32.92
  • ALKS $13.11
  • Revenue Growth
  • TFPM 45.86
  • ALKS N/A
  • 52 Week Low
  • TFPM $14.51
  • ALKS $25.17
  • 52 Week High
  • TFPM $29.30
  • ALKS $36.45
  • Technical
  • Relative Strength Index (RSI)
  • TFPM 59.75
  • ALKS 45.33
  • Support Level
  • TFPM $27.89
  • ALKS $26.40
  • Resistance Level
  • TFPM $29.30
  • ALKS $28.65
  • Average True Range (ATR)
  • TFPM 0.81
  • ALKS 1.11
  • MACD
  • TFPM 0.01
  • ALKS -0.27
  • Stochastic Oscillator
  • TFPM 64.64
  • ALKS 34.05

About TFPM Triple Flag Precious Metals Corp.

Triple Flag Precious Metals Corp is a streaming and royalty company focused on precious metals. Its revenues are largely generated from a diversified portfolio of properties in Australia, Canada, Colombia, Cote d'Ivoire, Mexico, Mongolia, Peru, South Africa, and the United States. Its diversified portfolio of streams and royalties comprises long-life mining assets, including the Northparkes copper-gold mine in Australia, the Cerro Lindo polymetallic mine in Peru, the Fosterville gold mine in Australia, the Buritica gold mine in Colombia, and the Impala Bafokeng Operations in South Africa among others. A majority of its revenue is derived through its interests in various gold streams. Geographically, the company derives maximum revenue from Australia, followed by Peru and other regions.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: